|
Introduction
Heresco-Levy U
and Javit DC
Genetics of glutamatergic systems:
relevance for neuropsychiatric disorders
Ebstein RP
The N-methyl-D-aspartate (NMDA)
receptor hypofunction hypothesis of schizophrenia
Farber
NB
Glutamatergic neurochemical changes
in schizophrenin
Tsai GE
D-serine in the developing human
CNS: clinical implications
Fuchs SA
Ketamine as a probe of NMDA
receptor function in psychosis
D'Souza CD
The role of NMDAR modulation in the
treatment of cognitive deficits
Deutsch SI
Reuptake inhibitors of NMDAR-GLY
site agonists
Javitt DC
Modulation of glutamatergic
neurotransmission as secondary prevention intervention in
psychotic disorders
Heresco-Levy U
AMPA receptor ligands: pharmacology
and therapeutic potential
Goff DC
Metabotropic glutamate receptors as
target for novel psychotropic medications
Glutamatergic function as target
for novel antidepressants
Manji HK
The role of glutamate in anxiety
and related disorders
Phan KL
Emotional learning and glutamate:
novel applications
Ressler KJ
Glutamatergic function in autistic
disorder
Posey DJ
The role of glutamatergic systems
in the pathophysiology of addictive disorders
Eden Evins A
|
